venue:
the building of Theoretical Institute,
Second Faculty of Medicine,Charles University,
Plzeňská 221/130, Prague 5, Czech Republic



17. 10. 2019


17. 10. PELOUCH LECTURE HALL ROOM 109 ROOM 110
8.00-8.45 Registration
8.45-9.00 Welcome and Introduction
9.00-9.45 Lecture - Therapeutic Gene Editing in Humans (Peter Sýkora)
9.45-10.30 Lecture - End-of-Life Decisions
(Paul Vanden Berghe)
10.30-10.45 COFFEE BREAK
10.45-11.30 When to Stop? Artificial Nutrition and Hydrataion at the End of Life
(Adam Houska)
The Story of CRISPR How It Has Been Covered by Nature Journalism (Boris Cvek) Virtual Reality and Medicine I
(Zbyněk Pohořelský)
11.30-12.15 To Be or Not To Be? Questioning Resuscitaion at the End of Life
(Ondřej Kopecký)
12.15-13.30 LUNCH
13.30-14.15 Donation after Cardiac Death (Markus Christen) Clinical Ethics: Solving Ethical Dilemmas in Real World (Jaromír Matějek) Virtual Reality and Medicine II
(Zbyněk Pohořelský)
14.15-15.00 The Dead Donor Rule and Organ Transplantation (Kateřina Rusinová) Current Possibilities and Effectiveness of Prenatel and Preimplantaion Diagnostics
(Antonín Šípek, jr.)
15.00-15.15 COFFEE BREAK
15.15-16.00 Discussion - Therapeutic Gene Editing in Humans; (chair: Jakub Kuchař)
16.00-16.15 COFFEE BREAK
16.15-17.00 Discussion - End-of-Life Decisions; (chair: Martin Loučka)
17.00-17.30 COFFEE BREAK
17.30-19.30 Movie: 21 Grams (124 min.) Movie: Gattaca (106 min.) Movie: Extremis (24 min.) + recommendations for delivering bad news (Martin Loučka)
20.00 WELCOME PARTY (Live concert of the band Crossroad Bros)




18. 10. 2019


18. 10. PELOUCH LECTURE HALL ROOM 109
9.45-10.15 Lecture - Transplantation
(Nikola Biller-Andorno)
10.15-10.30 COFFEE BREAK
10.30-11.15 The Gift in Donations. Anatomical Donations as a Medical Choice or as an Identity Trait (Giovanni Spitale) Who Should Decide When the Patient is Unconscious? (Jiří Šimek)
SURVEY
11.15-12.00 Discussion - Transplantation; (chairs: Karolína Francová and Andreas Ferrari)
12.00-12.15 COFFEE BREAK
12.15-13.30 The Legal Status of Organs and Cells and Transplantation
(Zuzana Zoláková)
13.30-14.15 END OF THE SUMMER SCHOOL, EVALUATION/LUNCH



The event is under patronage of the dean of Second Faculty of Medicine, Charles University,
prof. MUDr. Vladimír Komárek, CSc.



Program



Section I:

END-OF-LIFE DECISIONS

KEY SPEAKER: Paul Vander Berghe

Director of the Federatie Palliatieve Zorg Vlaanderen vzw (Federation Palliative Care Flanders FPCF) since 2006

Paul Vander Berghe

Paul Vanden Berghe (1966) studied philosophy and theology at the Groot Seminarie Brugge, the Catholic University of Louvain (Leuven) and the Eberhard Karls Universität Tübingen. He received his MA in Theology with a thesis on Christology (1992) and his PhD in Philosophy on the Ethics of psychoanalysis (2001). From 2001 until 2006 he worked as a postdoctoral research fellow and substitute professor in ethics and anthropology at the University of Antwerp and from 2003 until 2006 also as part-time pastoral caregiver in Leuven (Heilig Hart Ziekenhuis & University Hospital Gasthuisberg).

He was a member of the editorial board of ‘Ethical Perspectives’ (1992-2000), ethical advisor in a care home for older people with severe dementia in Leuven (2009-2012) and member of the Board of Directors of the European Association for Palliative Care (2011-2015 & 2015-2019 as treasurer).

He is currently a member of the Federal Advisory Committee on Bioethics and a member of the Federal Evaluation Cell Palliative Care. Since 2017 he is also president of the board of directors of a home for the elderly.




Section II:

TRANSPLANTATION

KEY SPEAKER: Nikola Biller-Andorno

Director of the Institute of Biomedical Ethics and History of Medicine, University of Zurich, Switzerland

Nikola Biller-Andorno

Prof. Dr. med. Dr. phil. Nikola Biller-Andorno directs the Institute of Biomedical Ethics and History of Medicine, University of Zurich, Switzerland, which serves as WHO Collaborating Centre for Bioethics. She co-leads the PhD program “Biomedical Ethics and Law” and serves as Vice-President of the Clinical Ethics Committee of the University Hospital Zurich. She is also a member of the Research Ethics Committee of the Federal Institute of Technology Zurich, and an expert advisor to the Swiss Medical Board, an HTA agency providing clinical and cost effectiveness analyses of diagnostic and therapeutic interventions. From 2009 to 2011 she acted as President of the International Association of Bioethics.

She has been a Commonwealth Fund Harkness Fellow (2012-13), a Safra Network Fellow (2013-14) and a Visiting Professor of Biomedical Ethics (2012-14) at Harvard University. In 2016, she was elected as Fellow of the Collegium Helveticum, an Institute of Advanced Study sponsored by the University of Zurich, the Federal Institute of Technology Zurich, and the Zurich University of the Arts. In 2018, she obtained an additional qualification in Health Business Administration (MHBA).




Section III:

Therapeutic Gene Editing in Humans

KEY SPEAKER: Petr Sýkora

Director of the Centre for Bioethics University of Sts. Cyril and Methodius in Trnava, Slovakia

Petr Sýkora

Peter Sýkora studied microbiology and genetics at the Faculty of Science, Charles University in Prague, and for two decades he engaged in biomedical research. The results are published, for example, in Plasmid, Am. J. of The Medical Sciences, J. Bacteriol., J. Theor. Biol. Since the mid-1990s, he has also been more involved in bioethics. In 1997 he became an associate professor at Comenius University in Bratislava and in 2009 a professor of philosophy at Masaryk University in Brno.

He worked as a researcher (University of Glasgow, University of Massachusetts) or visiting professor (Emory University, King´s College, National University of Singapore). He deals with ethical aspects of biomedical donation ( M. Steinmann, P. Sykora and U. Wiesing, eds. Altruism reconsidered: exploring new approaches to property in human tissue, Ashgate 2009), usability of embryonic stem cells (A Tale of Two Countries: Czech and Slovak Stem Cell Biopolicies. In: Contested Cells. World Scientific-Imperial College Press 2010) and gene editing in humans (Germline gene therapy in the era of precise genome editing: How far should we go? In: The Ethics of Reproductive Genetic, Marta Soniewicka (ed.), Springer 2018). He is a member of the National Ethics Committee at the Ministry of Health, Slovakia.

Do you need some additional about this event? You can ask directly Mgr. et Mgr. Martin Zielina, Ph.D.

Copyright © 2019 Ing. Jakub Jirák - www.jakubjirak.com